All scientific staff – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

Home > Staff > Scientific

Mads Hald Andersen

Mads Hald Andersen

Clinical Professor


  1. 2017
  2. Published

    The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy. / Ahmad, Shamaila Munir; Martinenaite, Evelina; Holmström, Morten; Jørgensen, Mia Aaboe; Met, Özcan; Nastasi, Claudia; Klausen, Uffe; Donia, Marco; Pedersen, Lars Møller; Munksgaard, Lars; Ødum, Niels; Woetmann, Anders; Svane, Inge Marie; Andersen, Mads Hald.

    In: OncoImmunology (Online), 30.10.2017, p. e1390641.

    Research output: Research - peer-reviewJournal article

  3. Published

    Anti-regulatory T cells. / Andersen, Mads Hald.

    In: Seminars in Immunopathology, Vol. 39, No. 3, 2017, p. 317–326.

    Research output: Research - peer-reviewReview

  4. Published

    Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. / Donia, Marco; Harbst, Katja; van Buuren, Marit; Kvistborg, Pia; Lindberg, Mattias F; Andersen, Rikke; Idorn, Manja; Munir Ahmad, Shamaila; Ellebæk, Eva; Mueller, Anja; Fagone, Paolo; Nicoletti, Ferdinando; Libra, Massimo; Lauss, Martin; Hadrup, Sine Reker; Schmidt, Henrik; Andersen, Mads Hald; Thor Straten, Per; Nilsson, Jonas A; Schumacher, Ton N; Seliger, Barbara; Jönsson, Göran; Svane, Inge Marie.

    In: Cancer research, Vol. 77, No. 17, 01.09.2017, p. 4562-4566.

    Research output: Research - peer-reviewJournal article

  5. Published

    The role of dendritic cells in cancer. / Hansen, Morten; Andersen, Mads Hald.

    In: Seminars in Immunopathology, Vol. 39, No. 3, 2017, p. 307-316.

    Research output: Research - peer-reviewReview

  6. E-pub ahead of print

    The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy. / Holmström, M O; Martinenaite, E; Ahmad, S M; Met, Ö; Friese, C; Kjær, L; Riley, C H; Thor Straten, P; Svane, I M; Hasselbalch, H C; Andersen, M H.

    In: Leukemia, 2017.

    Research output: Research - peer-reviewJournal article

  7. Published

    The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms. / Holmström, Morten Orebo; Hjortso, M. D.; Ahmad, S. M.; Met, O.; Martinenaite, E.; Riley, C.; Straten, P.; Svane, I. M.; Hasselbalch, H. C.; Andersen, Mads Hald.

    In: Leukemia, Vol. 31, No. 2, 02.2017, p. 495-498.

    Research output: Research - peer-reviewComment/debate

  8. Published

    Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs. / Overgaard, Nana H; Frøsig, Thomas M; Jakobsen, Jeanne T; Buus, Søren; Andersen, Mads H; Jungersen, Gregers.

    In: Vaccine, Vol. 35, No. 42, 09.10.2017, p. 5629-5636.

    Research output: Research - peer-reviewJournal article

  9. 2016
  10. Published

    PD-L1-specific T cells. / Ahmad, Shamaila Munir; Borch, Troels Holz; Hansen, Morten; Andersen, Mads Hald.

    In: Cancer Immunology, Immunotherapy, Vol. 65, No. 7, 07.2016, p. 797-804.

    Research output: Research - peer-reviewReview

  11. Published

    Anti-regulatory T cells. / Andersen, Mads Hald.

    Københavns Universitet, 2016.

    Research output: ResearchDoctoral thesis

  12. Published

    Novel understanding of self-reactive T cells. / Andersen, Mads Hald.

    In: OncoImmunology, Vol. 5, No. 3, e1083672 , 03.2016.

    Research output: Research - peer-reviewEditorial

Previous 1 2 3 4 5 6 7 8 Next

ID: 13571778